詳細検索

詳細検索

お問い合わせ

Medical Collagen Market Insights, Competitive Landscape, and Market Forecast - 2033

Medical Collagen Market Insights, Competitive Landscape, and Market Forecast - 2033


The medical collagen market is steadily advancing as healthcare systems increasingly adopt biologically derived materials for therapeutic and surgical applications. Collagen, a fundamental protein ... もっと見る

 

 

出版社
Fairfield Market Research
フェアフィールドマーケットリサーチ
出版年月
2026年5月7日
電子版価格
US$4,995
シングルユーザライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常5営業日以内
ページ数
201
言語
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The medical collagen market is steadily advancing as healthcare systems increasingly adopt biologically derived materials for therapeutic and surgical applications. Collagen, a fundamental protein found in connective tissues, is widely recognized for its biocompatibility, structural strength, and regenerative properties. It is extensively used in wound care, orthopedic treatments, tissue engineering, and cosmetic procedures. As the global healthcare industry shifts toward minimally invasive treatments and regenerative medicine, collagen-based products are becoming indispensable. Continuous improvements in biomaterial engineering and rising clinical acceptance are further strengthening the role of collagen in modern medical practice.

Market Insights

The global medical collagen market is projected to reach US$ 453.2 million in 2026 and is expected to grow to US$ 686.9 million by 2033, expanding at a CAGR of 6.10% during the forecast period. This growth is driven by increasing demand for advanced wound healing solutions, rising surgical procedures, and expanding applications in regenerative medicine. Market players are focusing on product innovation, improved processing technologies, and enhanced safety profiles to meet growing clinical requirements. The adoption of collagen-based biomaterials is also rising due to their ability to accelerate healing, support tissue regeneration, and reduce recovery time.

Drivers

The increasing incidence of chronic wounds, burns, and surgical injuries is a major factor driving the demand for collagen-based medical products. Collagen dressings and scaffolds are highly effective in promoting faster healing and reducing complications, making them a preferred choice among healthcare professionals. Additionally, the growing geriatric population is contributing significantly to market growth, as aging individuals are more prone to degenerative diseases and require advanced treatment options.

Another key driver is the rapid expansion of the aesthetic and reconstructive surgery market. Collagen is widely used in dermal fillers and facial reconstruction procedures, which are gaining popularity globally. The rising focus on improving patient outcomes and minimizing surgical risks has increased the adoption of collagen-based solutions. Furthermore, advancements in biotechnology and tissue engineering are enabling the development of next-generation collagen products with enhanced functionality, supporting broader application areas.

Business Opportunity

The medical collagen market offers significant growth opportunities for manufacturers and investors. The development of recombinant and synthetic collagen is emerging as a promising area, addressing concerns related to traditional animal-derived sources. These advanced alternatives provide improved consistency, safety, and scalability, making them suitable for large-scale medical applications.

Emerging economies, particularly in Asia Pacific and Latin America, present substantial opportunities due to improving healthcare infrastructure, rising healthcare spending, and increasing awareness of advanced treatment options. Companies that focus on expanding their presence in these regions are likely to benefit from untapped market potential.

Additionally, the integration of collagen into drug delivery systems is gaining traction. Collagen-based carriers enable controlled drug release and targeted therapy, especially in chronic disease and oncology treatments. The growing use of collagen in dental procedures and implantology is also creating new avenues for market expansion. Strategic partnerships, mergers, and research collaborations are expected to play a crucial role in driving innovation and strengthening market positions.

Region Analysis

North America dominates the medical collagen market, supported by well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong presence of leading industry players. The region continues to lead in innovation and clinical research, contributing to sustained market growth.

Europe holds a significant share of the market, driven by increasing demand for regenerative therapies and supportive regulatory frameworks. Countries such as Germany, France, and the United Kingdom are at the forefront of adopting collagen-based medical solutions, supported by strong research capabilities.

Asia Pacific is anticipated to register the fastest growth during the forecast period. Rapid economic development, expanding healthcare systems, and increasing awareness about advanced medical treatments are key factors driving regional growth. Countries like China, India, and Japan are witnessing rising demand for collagen-based products across various medical applications.

Latin America and the Middle East & Africa are gradually emerging as potential markets, with improving healthcare access and increasing investments in medical infrastructure. Although these regions currently hold a smaller share, they offer long-term growth opportunities for industry participants.

Key Players

• Collagen Solutions plc

• DSM Biomedical

• Integra LifeSciences Holdings Corporation

• Smith & Nephew plc

• Zimmer Biomet Holdings, Inc.

• Medtronic plc

• Baxter International Inc.

• Johnson & Johnson

• Stryker Corporation

• CollPlant Biotechnologies Ltd.

• Advanced BioMatrix, Inc.

• Nitta Gelatin Inc.

• Gelita AG

• Rousselot

• Koken Co., Ltd.

Segmentation

By Source

• Bovine Collagen

• Porcine Collagen

• Marine Collagen

• Poultry Collagen

• Others

By Product Type

• Gelatin

• Hydrolyzed Collagen

• Native Collagen

• Others

By Physical Form

• Powder

• Gel

• Films & Sheets

• Suspensions

• Liquid, Solid, Semi-solid

By Type

• Injectable Collagen

• Topical Collagen

• Bioabsorbable Collagen

By End User

• Hospitals & Clinics

• Specialty Clinics

• Pharmaceutical & Biotechnology Companies

• Research Institutes & CROs

By Geography

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る


Table of Contents

1. Executive Summary
1.1. Global Medical Collagen Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Medical Collagen Market Outlook, 2020 - 2033
3.1. Global Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
3.1.1. Bovine Collagen
3.1.2. Porcine Collagen
3.1.3. Marine Collagen
3.1.4. Poultry Collagen
3.1.5. Others
3.2. Global Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
3.2.1. Gelatin
3.2.2. Hydrolyzed Collagen
3.2.3. Native Collagen
3.2.4. Others
3.3. Global Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
3.3.1. Powder
3.3.2. Gel
3.3.3. Films & Sheets
3.3.4. Suspensions
3.3.5. Liquid, Solid, Semi-solid
3.4. Global Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
3.4.1. Injectable Collagen
3.4.2. Topical Collagen
3.4.3. Bioabsorbable Collagen
3.5. Global Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
3.5.1. Hospitals & Clinics
3.5.2. Specialty Clinics
3.5.3. Pharmaceutical & Biotechnology Companies
3.5.4. Research Institutes & CROs
3.6. Global Medical Collagen Market Outlook, by Region, Value (US$ Mn), 2020-2033
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Latin America
3.6.5. Middle East & Africa
4. North America Medical Collagen Market Outlook, 2020 - 2033
4.1. North America Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
4.1.1. Bovine Collagen
4.1.2. Porcine Collagen
4.1.3. Marine Collagen
4.1.4. Poultry Collagen
4.1.5. Others
4.2. North America Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
4.2.1. Gelatin
4.2.2. Hydrolyzed Collagen
4.2.3. Native Collagen
4.2.4. Others
4.3. North America Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
4.3.1. Powder
4.3.2. Gel
4.3.3. Films & Sheets
4.3.4. Suspensions
4.3.5. Liquid, Solid, Semi-solid
4.4. North America Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
4.4.1. Injectable Collagen
4.4.2. Topical Collagen
4.4.3. Bioabsorbable Collagen
4.5. North America Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
4.5.1. Hospitals & Clinics
4.5.2. Specialty Clinics
4.5.3. Pharmaceutical & Biotechnology Companies
4.5.4. Research Institutes & CROs
4.6. North America Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
4.6.1. U.S. Medical Collagen Market Outlook, by Source, 2020-2033
4.6.2. U.S. Medical Collagen Market Outlook, by Product Type, 2020-2033
4.6.3. U.S. Medical Collagen Market Outlook, by Physical Form, 2020-2033
4.6.4. U.S. Medical Collagen Market Outlook, by Type, 2020-2033
4.6.5. U.S. Medical Collagen Market Outlook, by End User, 2020-2033
4.6.6. Canada Medical Collagen Market Outlook, by Source, 2020-2033
4.6.7. Canada Medical Collagen Market Outlook, by Product Type, 2020-2033
4.6.8. Canada Medical Collagen Market Outlook, by Physical Form, 2020-2033
4.6.9. Canada Medical Collagen Market Outlook, by Type, 2020-2033
4.6.10. Canada Medical Collagen Market Outlook, by End User, 2020-2033
4.7. BPS Analysis/Market Attractiveness Analysis
5. Europe Medical Collagen Market Outlook, 2020 - 2033
5.1. Europe Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
5.1.1. Bovine Collagen
5.1.2. Porcine Collagen
5.1.3. Marine Collagen
5.1.4. Poultry Collagen
5.1.5. Others
5.2. Europe Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
5.2.1. Gelatin
5.2.2. Hydrolyzed Collagen
5.2.3. Native Collagen
5.2.4. Others
5.3. Europe Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
5.3.1. Powder
5.3.2. Gel
5.3.3. Films & Sheets
5.3.4. Suspensions
5.3.5. Liquid, Solid, Semi-solid
5.4. Europe Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
5.4.1. Injectable Collagen
5.4.2. Topical Collagen
5.4.3. Bioabsorbable Collagen
5.5. Europe Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
5.5.1. Hospitals & Clinics
5.5.2. Specialty Clinics
5.5.3. Pharmaceutical & Biotechnology Companies
5.5.4. Research Institutes & CROs
5.6. Europe Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
5.6.1. Germany Medical Collagen Market Outlook, by Source, 2020-2033
5.6.2. Germany Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.3. Germany Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.4. Germany Medical Collagen Market Outlook, by Type, 2020-2033
5.6.5. Germany Medical Collagen Market Outlook, by End User, 2020-2033
5.6.6. Italy Medical Collagen Market Outlook, by Source, 2020-2033
5.6.7. Italy Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.8. Italy Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.9. Italy Medical Collagen Market Outlook, by Type, 2020-2033
5.6.10. Italy Medical Collagen Market Outlook, by End User, 2020-2033
5.6.11. France Medical Collagen Market Outlook, by Source, 2020-2033
5.6.12. France Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.13. France Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.14. France Medical Collagen Market Outlook, by Type, 2020-2033
5.6.15. France Medical Collagen Market Outlook, by End User, 2020-2033
5.6.16. U.K. Medical Collagen Market Outlook, by Source, 2020-2033
5.6.17. U.K. Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.18. U.K. Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.19. U.K. Medical Collagen Market Outlook, by Type, 2020-2033
5.6.20. U.K. Medical Collagen Market Outlook, by End User, 2020-2033
5.6.21. Spain Medical Collagen Market Outlook, by Source, 2020-2033
5.6.22. Spain Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.23. Spain Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.24. Spain Medical Collagen Market Outlook, by Type, 2020-2033
5.6.25. Spain Medical Collagen Market Outlook, by End User, 2020-2033
5.6.26. Russia Medical Collagen Market Outlook, by Source, 2020-2033
5.6.27. Russia Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.28. Russia Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.29. Russia Medical Collagen Market Outlook, by Type, 2020-2033
5.6.30. Russia Medical Collagen Market Outlook, by End User, 2020-2033
5.6.31. Rest of Europe Medical Collagen Market Outlook, by Source, 2020-2033
5.6.32. Rest of Europe Medical Collagen Market Outlook, by Product Type, 2020-2033
5.6.33. Rest of Europe Medical Collagen Market Outlook, by Physical Form, 2020-2033
5.6.34. Rest of Europe Medical Collagen Market Outlook, by Type, 2020-2033
5.6.35. Rest of Europe Medical Collagen Market Outlook, by End User, 2020-2033
5.7. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Medical Collagen Market Outlook, 2020 - 2033
6.1. Asia Pacific Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
6.1.1. Bovine Collagen
6.1.2. Porcine Collagen
6.1.3. Marine Collagen
6.1.4. Poultry Collagen
6.1.5. Others
6.2. Asia Pacific Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
6.2.1. Gelatin
6.2.2. Hydrolyzed Collagen
6.2.3. Native Collagen
6.2.4. Others
6.3. Asia Pacific Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
6.3.1. Powder
6.3.2. Gel
6.3.3. Films & Sheets
6.3.4. Suspensions
6.3.5. Liquid, Solid, Semi-solid
6.4. Asia Pacific Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
6.4.1. Injectable Collagen
6.4.2. Topical Collagen
6.4.3. Bioabsorbable Collagen
6.5. Asia Pacific Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
6.5.1. Hospitals & Clinics
6.5.2. Specialty Clinics
6.5.3. Pharmaceutical & Biotechnology Companies
6.5.4. Research Institutes & CROs
6.6. Asia Pacific Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
6.6.1. China Medical Collagen Market Outlook, by Source, 2020-2033
6.6.2. China Medical Collagen Market Outlook, by Product Type, 2020-2033
6.6.3. China Medical Collagen Market Outlook, by Physical Form, 2020-2033
6.6.4. China Medical Collagen Market Outlook, by Type, 2020-2033
6.6.5. China Medical Collagen Market Outlook, by End User, 2020-2033
6.6.6. Japan Medical Collagen Market Outlook, by Source, 2020-2033
6.6.7. Japan Medical Collagen Market Outlook, by Product Type, 2020-2033
6.6.8. Japan Medical Collagen Market Outlook, by Physical Form, 2020-2033
6.6.9. Japan Medical Collagen Market Outlook, by Type, 2020-2033
6.6.10. Japan Medical Collagen Market Outlook, by End User, 2020-2033
6.6.11. South Korea Medical Collagen Market Outlook, by Source, 2020-2033
6.6.12. South Korea Medical Collagen Market Outlook, by Product Type, 2020-2033
6.6.13. South Korea Medical Collagen Market Outlook, by Physical Form, 2020-2033
6.6.14. South Korea Medical Collagen Market Outlook, by Type, 2020-2033
6.6.15. South Korea Medical Collagen Market Outlook, by End User, 2020-2033
6.6.16. India Medical Collagen Market Outlook, by Source, 2020-2033
6.6.17. India Medical Collagen Market Outlook, by Product Type, 2020-2033
6.6.18. India Medical Collagen Market Outlook, by Physical Form, 2020-2033
6.6.19. India Medical Collagen Market Outlook, by Type, 2020-2033
6.6.20. India Medical Collagen Market Outlook, by End User, 2020-2033
6.6.21. Southeast Asia Medical Collagen Market Outlook, by Source, 2020-2033
6.6.22. Southeast Asia Medical Collagen Market Outlook, by Product Type, 2020-2033
6.6.23. Southeast Asia Medical Collagen Market Outlook, by Physical Form, 2020-2033
6.6.24. Southeast Asia Medical Collagen Market Outlook, by Type, 2020-2033
6.6.25. Southeast Asia Medical Collagen Market Outlook, by End User, 2020-2033
6.6.26. Rest of SAO Medical Collagen Market Outlook, by Source, 2020-2033
6.6.27. Rest of SAO Medical Collagen Market Outlook, by Product Type, 2020-2033
6.6.28. Rest of SAO Medical Collagen Market Outlook, by Physical Form, 2020-2033
6.6.29. Rest of SAO Medical Collagen Market Outlook, by Type, 2020-2033
6.6.30. Rest of SAO Medical Collagen Market Outlook, by End User, 2020-2033
6.7. BPS Analysis/Market Attractiveness Analysis
7. Latin America Medical Collagen Market Outlook, 2020 - 2033
7.1. Latin America Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
7.1.1. Bovine Collagen
7.1.2. Porcine Collagen
7.1.3. Marine Collagen
7.1.4. Poultry Collagen
7.1.5. Others
7.2. Latin America Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
7.2.1. Gelatin
7.2.2. Hydrolyzed Collagen
7.2.3. Native Collagen
7.2.4. Others
7.3. Latin America Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
7.3.1. Powder
7.3.2. Gel
7.3.3. Films & Sheets
7.3.4. Suspensions
7.3.5. Liquid, Solid, Semi-solid
7.4. Latin America Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
7.4.1. Injectable Collagen
7.4.2. Topical Collagen
7.4.3. Bioabsorbable Collagen
7.5. Latin America Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
7.5.1. Hospitals & Clinics
7.5.2. Specialty Clinics
7.5.3. Pharmaceutical & Biotechnology Companies
7.5.4. Research Institutes & CROs
7.6. Latin America Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
7.6.1. Brazil Medical Collagen Market Outlook, by Source, 2020-2033
7.6.2. Brazil Medical Collagen Market Outlook, by Product Type, 2020-2033
7.6.3. Brazil Medical Collagen Market Outlook, by Physical Form, 2020-2033
7.6.4. Brazil Medical Collagen Market Outlook, by Type, 2020-2033
7.6.5. Brazil Medical Collagen Market Outlook, by End User, 2020-2033
7.6.6. Mexico Medical Collagen Market Outlook, by Source, 2020-2033
7.6.7. Mexico Medical Collagen Market Outlook, by Product Type, 2020-2033
7.6.8. Mexico Medical Collagen Market Outlook, by Physical Form, 2020-2033
7.6.9. Mexico Medical Collagen Market Outlook, by Type, 2020-2033
7.6.10. Mexico Medical Collagen Market Outlook, by End User, 2020-2033
7.6.11. Argentina Medical Collagen Market Outlook, by Source, 2020-2033
7.6.12. Argentina Medical Collagen Market Outlook, by Product Type, 2020-2033
7.6.13. Argentina Medical Collagen Market Outlook, by Physical Form, 2020-2033
7.6.14. Argentina Medical Collagen Market Outlook, by Type, 2020-2033
7.6.15. Argentina Medical Collagen Market Outlook, by End User, 2020-2033
7.6.16. Rest of LATAM Medical Collagen Market Outlook, by Source, 2020-2033
7.6.17. Rest of LATAM Medical Collagen Market Outlook, by Product Type, 2020-2033
7.6.18. Rest of LATAM Medical Collagen Market Outlook, by Physical Form, 2020-2033
7.6.19. Rest of LATAM Medical Collagen Market Outlook, by Type, 2020-2033
7.6.20. Rest of LATAM Medical Collagen Market Outlook, by End User, 2020-2033
7.7. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Medical Collagen Market Outlook, 2020 - 2033
8.1. Middle East & Africa Medical Collagen Market Outlook, by Source, Value (US$ Mn), 2020-2033
8.1.1. Bovine Collagen
8.1.2. Porcine Collagen
8.1.3. Marine Collagen
8.1.4. Poultry Collagen
8.1.5. Others
8.2. Middle East & Africa Medical Collagen Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
8.2.1. Gelatin
8.2.2. Hydrolyzed Collagen
8.2.3. Native Collagen
8.2.4. Others
8.3. Middle East & Africa Medical Collagen Market Outlook, by Physical Form, Value (US$ Mn), 2020-2033
8.3.1. Powder
8.3.2. Gel
8.3.3. Films & Sheets
8.3.4. Suspensions
8.3.5. Liquid, Solid, Semi-solid
8.4. Middle East & Africa Medical Collagen Market Outlook, by Type, Value (US$ Mn), 2020-2033
8.4.1. Injectable Collagen
8.4.2. Topical Collagen
8.4.3. Bioabsorbable Collagen
8.5. Middle East & Africa Medical Collagen Market Outlook, by End User, Value (US$ Mn), 2020-2033
8.5.1. Hospitals & Clinics
8.5.2. Specialty Clinics
8.5.3. Pharmaceutical & Biotechnology Companies
8.5.4. Research Institutes & CROs
8.6. Middle East & Africa Medical Collagen Market Outlook, by Country, Value (US$ Mn), 2020-2033
8.6.1. GCC Medical Collagen Market Outlook, by Source, 2020-2033
8.6.2. GCC Medical Collagen Market Outlook, by Product Type, 2020-2033
8.6.3. GCC Medical Collagen Market Outlook, by Physical Form, 2020-2033
8.6.4. GCC Medical Collagen Market Outlook, by Type, 2020-2033
8.6.5. GCC Medical Collagen Market Outlook, by End User, 2020-2033
8.6.6. South Africa Medical Collagen Market Outlook, by Source, 2020-2033
8.6.7. South Africa Medical Collagen Market Outlook, by Product Type, 2020-2033
8.6.8. South Africa Medical Collagen Market Outlook, by Physical Form, 2020-2033
8.6.9. South Africa Medical Collagen Market Outlook, by Type, 2020-2033
8.6.10. South Africa Medical Collagen Market Outlook, by End User, 2020-2033
8.6.11. Egypt Medical Collagen Market Outlook, by Source, 2020-2033
8.6.12. Egypt Medical Collagen Market Outlook, by Product Type, 2020-2033
8.6.13. Egypt Medical Collagen Market Outlook, by Physical Form, 2020-2033
8.6.14. Egypt Medical Collagen Market Outlook, by Type, 2020-2033
8.6.15. Egypt Medical Collagen Market Outlook, by End User, 2020-2033
8.6.16. Nigeria Medical Collagen Market Outlook, by Source, 2020-2033
8.6.17. Nigeria Medical Collagen Market Outlook, by Product Type, 2020-2033
8.6.18. Nigeria Medical Collagen Market Outlook, by Physical Form, 2020-2033
8.6.19. Nigeria Medical Collagen Market Outlook, by Type, 2020-2033
8.6.20. Nigeria Medical Collagen Market Outlook, by End User, 2020-2033
8.6.21. Rest of Middle East Medical Collagen Market Outlook, by Source, 2020-2033
8.6.22. Rest of Middle East Medical Collagen Market Outlook, by Product Type, 2020-2033
8.6.23. Rest of Middle East Medical Collagen Market Outlook, by Physical Form, 2020-2033
8.6.24. Rest of Middle East Medical Collagen Market Outlook, by Type, 2020-2033
8.6.25. Rest of Middle East Medical Collagen Market Outlook, by End User, 2020-2033
8.7. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Collagen Solutions plc
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. DSM Biomedical
9.4.3. Integra LifeSciences Holdings Corporation
9.4.4. Smith & Nephew plc
9.4.5. Zimmer Biomet Holdings, Inc.
9.4.6. Medtronic plc
9.4.7. Baxter International Inc.
9.4.8. Johnson & Johnson
9.4.9. Stryker Corporation
9.4.10. CollPlant Biotechnologies Ltd.
9.4.11. Advanced BioMatrix, Inc.
9.4.12. Nitta Gelatin Inc.
9.4.13. Gelita AG
9.4.14. Rousselot
9.4.15. Koken Co., Ltd.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


Fairfield Market Research社はどのような調査会社ですか?


Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/06/08 10:26

161.38 円

186.42 円

218.06 円

ページTOPに戻る